New Nanorobotic Agents Precisely Administer Anti-Cancer Drugs

NewsImage_34960A research team from Polytechnique Montréal, McGill University, and Université de Montréal has successfully developed novel nanorobotic agents that travel through the bloodstream and precisely inject a drug by targeting the active regions of cancerous tumors. The study represents a scientific breakthrough in cancer research.

This precise way of administering medication not only ensures the specific targeting of tumors, but also protects the integrity of organs and the adjacent healthy tissues. The intake of highly toxic drugs by human begins can be considerably reduced.

The study has been reported in the prestigious Nature Nanotechnology journal in an article titled “Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions.” The article describes the outcome of the study performed on mice, whose colorectal tumors were injected with nanorobotic agents.

By AZoNano



About Peter Coffaro 1104 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.